New Frontiers for Neurology Laboratory Medicine
Webinar
Ultrasensitive immunoassays have launched an explosion of research on blood biomarkers for a variety of neurological indications, spanning acute conditions such as traumatic brain and spinal cord injury to chronic conditions including multiple sclerosis, neurodegenerative disease, and dementia.
This webcast will focus on neurology blood biomarker research, highlighting Canadian assets that can be leveraged toward analytical and clinical validation studies.
Key Learning Points:
- How ultra-sensitivity allows for greater depth of exploration in neurological research
- Which immunoassays are currently most prevalent in neurological research
- The analytical and clinical validation process and how to use ultrasensitive immunoassays to achieve it
About the Speaker:
Dr. Cheryl Wellington, Professor
Department of Pathology and Laboratory Medicine
University of British Columbia
Dr. Cheryl Wellington is a professor at the University of British Columbia whose research is highly multidisciplinary with major efforts in Alzheimer’s Disease and Traumatic Brain Injury. Her laboratory is the leading Canadian site for research on blood biomarkers using the Quanterix single molecule array (Simoa) platform.